Spain funded 17 new orphan drugs in 2024, totaling 85 within the NHS, covering 58% of EU-approved orphan medicines. Three advanced therapies were funded, the first...
AseBio and Aelmhu praised the first Joint Committee meeting on Spain’s 2024-2028 Pharmaceutical Industry Strategy, emphasizing collaboration between ministries and industry. AseBio supports fostering biotechnology growth,...